Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials

O Mitjà, G Reis, DR Boulware… - Clinical and …, 2023 - Wiley Online Library
Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of
coronavirus disease 2019 (COVID‐19). Conventional meta‐analyses cannot fully address …

[HTML][HTML] Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials

O Mitjà, G Reis, DR Boulware, AM Spivak… - Clinical and …, 2023 - ncbi.nlm.nih.gov
Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of
coronavirus disease 2019 (COVID‐19). Conventional meta‐analyses cannot fully address …

[PDF][PDF] Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials

2023 - scholar.archive.org
Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of
coronavirus disease 2019 (COVID-19). Conventional meta-analyses cannot fully address …

Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials

O Mitjà, G Reis, DR Boulware, AM Spivak… - Clinical and …, 2023 - experts.umn.edu
Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of
coronavirus disease 2019 (COVID-19). Conventional meta-analyses cannot fully address …

Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials

O Mitjà, G Reis, DR Boulware… - Clinical and …, 2023 - pubmed.ncbi.nlm.nih.gov
Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of
coronavirus disease 2019 (COVID-19). Conventional meta-analyses cannot fully address …

[引用][C] Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials

O Mitja, G Reis, DR Boulware… - Cts-Clinical and …, 2023 - ub01.uni-tuebingen.de
Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of
individual participant data of randomized trials Hydroxychloroquine for treatment of non-hospitalized …

Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials

O Mitjà, G Reis, DR Boulware, AM Spivak… - Clinical and …, 2023 - cdr.lib.unc.edu
Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of
coronavirus disease 2019 (COVID-19). Conventional meta-analyses cannot fully address …

Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials.

O Mitjà, G Reis, DR Boulware, AM Spivak… - Clinical and …, 2023 - europepmc.org
Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of
coronavirus disease 2019 (COVID‐19). Conventional meta‐analyses cannot fully address …

Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials

O Mitjà, G Reis, DR Boulware… - Clinical and …, 2023 - search.proquest.com
Hydroxychloroquine (HCQ) was initially promoted as an oral therapy for early treatment of
coronavirus disease 2019 (COVID-19). Conventional meta-analyses cannot fully address …

[引用][C] Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials

O Mitja, G Reis, DR Boulware… - Cts-Clinical and …, 2023 - tobias-lib.ub.uni-tuebingen.de
Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of
individual participant data of randomized trials Hydroxychloroquine for treatment of non-hospitalized …